Abbott Laboratories (ABT) Stock Chart

NYSE
$103.08+0.11 (+0.11%)After hours

View the Abbott Laboratories stock chart with market data, key statistics, volume, financial metrics, latest news, and exportable historical data.

Source
Nasdaq Real Time Price
Quote Time
Oct 14, 2026, 8:50 PM UTC
Delay
20 min source-reported delay

Market data is for research and educational use only, not investment advice. Quotes may be delayed depending on the source and exchange; verify important prices with your broker or data provider.

Read the ABT trend first

Use the range controls to compare short-term moves with the longer-term Abbott Laboratories stock chart. A move that looks large on 1D can look routine on a 1Y or 5Y chart.

Check price with volume

Volume helps show whether a move happened with broad participation or thin trading. Compare recent bars with the average volume and news context before drawing conclusions.

Verify before acting

This page is built for research and education. Quotes, analyst fields, and news can be delayed or revised, so verify important prices with your broker or primary data provider.

Key Statistics

Previous Close$102.61
Open$104.06
Day Range$101.69 — $104.06
52 Wk Range$81.97 — $132.03
Volume7,272,392
Avg Volume9,532,326
Market Cap178.18B
P/E (TTM)33.22
P/E (Fwd)16.97
EPS (TTM)$3.10
Dividend Yield2.46%
Beta0.58
50 Day Avg$106.00
200 Day Avg$103.12
Shares Out1.73B
PEG Ratio1.88
Price/Book3.49

Financial Metrics

Revenue
46.58B
Revenue Growth
13.00%
Gross Margin
56.85%
Operating Margin
14.71%
Profit Margin
11.65%
Return on Equity
10.58%
Total Cash
5.60B
Total Debt
32.72B
Free Cash Flow
7.21B
Analyst Target
$120.72
Analyst Consensus
Strong Buy
Analyst Opinions
26

About Abbott Laboratories

Sector
Healthcare
Industry
Medical Devices
Employees
122,000
Headquarters
Abbott Park, IL, United States
Website
abbott.com
CEO
Mr. Robert B. Ford

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Related Charts

Data Definitions

Previous close

The most recent prior regular-session close reported by the market data source.

Day range

The source-reported high and low for the current or most recent trading session.

Volume

The number of shares, units, contracts, or asset quantity reported as traded during the period.

Moving averages

The 50-day and 200-day averages smooth recent prices to give quick trend context.

Market cap

A company or fund size estimate based on price and shares outstanding when source data is available.

P/E ratio

Price divided by earnings per share. It is most useful when compared with peers and growth expectations.